Sherman L A, Lee J
J Exp Med. 1977 Jan 1;145(1):76-85. doi: 10.1084/jem.145.1.76.
Guinea pig peritoneal macrophages were demonstrated to bind selectively soluble 125I-fibrin and fibrin/fibrinogen complexes as compared with fibrinogen, fibrinogen degradation products, and fibrin degradation products. Cellular uptake was considered to be surface receptor binding on the basis of removal of bound 125I-fibrin by trypsin and because uptake occurred in the presence of metabolic inhibitors. 125I-fibrin uptake could be blocked by nonradioactive fibrin but not by IgG or immune complexes. Binding was uneffected by prior treatment with plasmin or trypsin but was calcium dependent. Only limited reversibility of binding could be demonstrated after prolonged incubation. Scatchard plots permitted an estimate of the number of bound molecules. At saturation 6.92 X 10(6) 125I-fibrin molecules were bound per cell. Similar binding of fibrin was noted in polymorphonuclear leukocytes, but not lymphocytes or fibroblasts. Soluble fibrin binding may be a host defense mechanism whereby the reticuloendothelial system can remove fibrin from the blood before the development of microthrombi.
与纤维蛋白原、纤维蛋白原降解产物及纤维蛋白降解产物相比,豚鼠腹腔巨噬细胞被证明能选择性结合可溶性125I-纤维蛋白及纤维蛋白/纤维蛋白原复合物。基于胰蛋白酶可去除结合的125I-纤维蛋白以及摄取在代谢抑制剂存在的情况下仍会发生,细胞摄取被认为是表面受体结合。125I-纤维蛋白摄取可被非放射性纤维蛋白阻断,但不能被IgG或免疫复合物阻断。结合不受纤溶酶或胰蛋白酶预处理的影响,但依赖于钙。长时间孵育后仅能证明结合具有有限的可逆性。Scatchard图可用于估计结合分子的数量。饱和时,每个细胞结合6.92×10(6)个125I-纤维蛋白分子。在多形核白细胞中也观察到类似的纤维蛋白结合,但淋巴细胞或成纤维细胞中未观察到。可溶性纤维蛋白结合可能是一种宿主防御机制,借此网状内皮系统可在微血栓形成之前从血液中清除纤维蛋白。